English
This article is from Urology Annals , volume 6 . Abstract Aim:: To report safety and efficacy of chemotherapy incorporating the combination of paclitaxel and platinum in patients with advanced penile carcinoma. Materials and Methods:: Retrospective analysis of patient with advanced penile carcinoma undergoing palliative chemotherapy with paclitaxel and platinum combination. The demographic profile, indication of treatment, chemotherapy details, toxicity and survival outcome were noted. Statistical analysis was done for estimation of progression free survival and overall survival. Factors affecting these outcomes were sought for. Results:: Eighteen patients with a median age of 47.5 years (31-68 years) were offered palliative intent chemotherapy over a period of 2.5 years. ECOG performance was 1 in 12 patients (66.7%) and 2 in 6 patients (33.3%). The grade of tumor was poorly differentiated in 8 patients (44.4%), moderately differentiated in 5 (27.8%) and we1l differentiated in 5 patients (27.8%). Twelve patients had previous surgical treatment (66.7%), with 2 of them having received groin radiation in past. The indication for treatment was metastatic disease in 7 patients (38.9%) a
Sign in with your free account to read, download EPUBs or listen.
Ebook · Palliative chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise? · Patil, Vijay M, Noronha, Vanita, Joshi, Amit, Muddu, Vamshi, Bhosale, Bharat, Bakshi, Ganesh, Prabhash, Kumar · Internet Archive